Vivanza Biosciences Ltd.BSE: VIVANZA

Financial Results For The Quarter Ended 30Th September, 2025

· Issued by Vivanza Biosciences Ltd. via BSE India

Pursuant to Regulation 30 and 33 of the SEBI (LODR) Regulations, 2015 we wish to inform that the board of directors at its meeting held tuesday 11th November, 2025 has inter alia considered and approved (1) unaudited standalone and consolidated financial results for the quarter ended 30th September, 2025 alongwith the limited review report (2) Appointment of CS Chaitra Arora (M.No. A78376) as Company Secretary & compliance officer and noted the resignation of CS siddhi shah (M. No. A44885) (3) Alteration of main object clause of the Memorandum of association to include manufacturing and trading of plastic and packaging materials subject to shareholders'' approval via postal ballot (4) Approval of postal ballot notice, calendar of events, cut- off date of 7th November, 2025 and appointment of Mr. Chintan K. Patel as a Scrutinizer.

View Attachment

View original source (BSE India)Vivanza Biosciences Ltd. on 6ix

Earlier from Vivanza Biosciences

Later from Vivanza Biosciences

All Vivanza Biosciences news releases